OCULAR MANIFESTATIONS OF SARCOIDOSIS

OCULAR MANIFESTATIONS OF SARCOIDOSIS

Dr.Rajesh Babu BMS, FMRF, MSc (CEH) , DLSHTM, UK

ConsultantUveitis & Ocular Immunology

Ocular Epidemiology & Community Eye HealthNarayana Nethralaya , Bangalore

Ocular Sarcoidosis• Definition• Epidemiology• Theories of pathogenesis• Clinical manifestations • Symptoms• Complications• Pathology• Differential diagnosis• Investigations• Treatment• Prognosis

Definition

• Sarcoidosis is a chronic multisystemic granulomatous disorder of unknown etiology thought to result from an exaggerated cellular immune response to a variety of self antigens or non-self antigens that is characterized by its pathological hallmark, the noncaseating granuloma.

• The illness can be self-limited or chronic Episodic recrudescence and remissions.

• Because the lungs and thoracic lymph nodes are almost always involved, most patients report acute or insidious respiratory problems, variably accompanied by symptoms affecting the skin, eyes, or other organs.

Epidemiology

• Sarcoidosis occurs worldwide.

• Affecting persons of all races, both sexes, and all ages.

• It has a particular proclivity for adults < age of 40 and

for certain ethnic and racial groups (US blacks,

Scandinavian and Irish white people).

• The lifetime risk of sarcoidosis for U.S. blacks is 2.4

percent, and that for U.S. whites 0.85 percent.

Epidemiology

• The frequency of sarcoidosis is reported to be low in various parts of the world.

• It is not known whether this low frequency of sarcoidosis is genuine or whether it represents an underdiagnosis owing to the frequent occurrence of subclinical course, similarity with other diseases, or absence of firm diagnostic criteria.

Etiopathogenesis

• The cause of sarcoidosis remains obscure for a number of reasons

– The heterogeneity of the manifestations of the disease

– The lack of a precise definition

• Clinical overlap with other disorders

• and insensitive and nonspecific diagnostic tests that lead to

misclassification of the disease .

• Mycobacterium remain leading suspects.

• Transmission after cardiac /bone-marrow transplant has been reported

1. Almenoff PL, Johnson A, Lesser M, Mattman LH. Growth of acid fast L forms from the blood of patients with sarcoidosis. Thorax 1996;51:530-533.2. Burke WMJ, Keogh A, Maloney PJ, Delprado W, Bryant DH, Spratt P. Transmission of sarcoidosis via cardiac transplantation. Lancet 1990;336:1579-1579.3. Heyll A, Meckenstock G, Aul C, et al. Possible transmission of sarcoidosis via allogeneic bone marrow transplantation. Bone Marrow Transplant 1994;14:161-164.

Theories of pathogenesis

The diverse manifestations of this disorder help

fuel the prevailing hypothesis that sarcoidosis

has more than one cause, each of which

may promote a different pattern of illness.

Theories of pathogenesis

Conceptually, it appears likely that

Genetically predisposed hosts are exposed to

antigens that trigger an exaggerated cellular

immune response and the formation of

granulomas.

PATHOLOGICAL AND IMMUNOLOGIC

FEATURES

Non-caseating granuloma holds the key to the diagnosis of sarcoidosis and provides clues to the immunopathogenesis of the disease.

Clinical Manifestations

• Can be widespread or may involve only one organ system at a time.

• Two peaks of incidence - the first at ages 20–30 years and the second at ages 50–60 years.

• Ocular involvement manifests in 25%–60% of patients with systemic sarcoidosis.

Albert DM, Jakobiec FAHunter DG, Foster CS(1994) Ocular manifestations of sarcoidosis. in Principles and practice of ophthalmology . eds Albert DM, Jakobiec FA(WB Saunders, Philadelphia), pp 443–450.

Symptoms

•The majority of patients, however, present with systemic

symptoms such as fatigue, anorexia, weight loss, and fever .

•Many report dyspnea on exertion, retrosternal chest pain, and

cough .

•This may precede of come many months and years later.

•Ocular symptoms related to chronic granulomatous uveitis

•Lid nodules, conjunctival injection and nodules, rarely proptosis

Symptoms

In 20 to 50 percent of the patients with more acute

presentations, one sees the constellation of

Erythema Nodosum

Bilateral hilar lymphadenopathy

Polyarthralgias, known as Löfgren's syndrome.

Parotid involvement with uveitis is called Herfordt syndrome.

Examination findings

• Ophthalmic lesions develop in approximately 25 percent of patients.

• The classic symptom of anterior uveitis has a rapid onset, with blurred vision, photophobia, and excessive lacrimation; it usually clears spontaneously within a year.

• Conjunctival involvement with small, pale, yellow nodules is common.

• The most common ocular manifestations are uveitis (30%–70%) and conjunctival nodules (40%)

• More than 80% of uveitis cases manifested before or within 1 year after the onset of systemic disease.

RIGHT EYE

•DIFFUSE MUTTON FAT KERATIC PRECIPITATES •AQUEOUS FLARE ++•AQUEOUS CELLS ++•FIBRIN PRESENT•IRIS NODULES •LENS CLEAR•NO VITREOUS REACTION

Multiple koeppe’s and bussaca nodules

CONJUNCTIVAL NODULES

Conjunctival involvement has been reported in 6.9 - 70% of patients with ocular sarcoidosisSarcoidosis granulomas are described as solitary, yellow "millet-seed" nodules.

Posterior segment manifestations

Intermediate Uveitis

Posterior segment manifestations

Active sarcoid granulomas

Disc edema

Complications

• The clinical impact of sarcoidosis is directly related to the

extent of granulomatous inflammation and its effect on the

function of vital organs.

Specimens should be obtained from the most readily accessible organ with

the least invasive method.

Complications

• The clinical impact of sarcoidosis is directly related to the

extent of granulomatous inflammation and its effect on the

function of vital organs.

Specimens should be obtained from the most readily accessible organ with

the least invasive method.

Pathology

Small focus of necrosis. The most common appearance of necrosis in sarcoidosis

Rather like a rugby scrum with all the players grouped around the ball;

only with sarcoidosis the ball is invisible.

Small focus of necrosis

Granulomas involving a bronchiole

Angiotensin converting enzyme (ACE)

• ACE is normally present in the vascular endothelium of many organs (lung,

kidney, small intestine, uterus, prostate, thyroid, testes, adrenals) and in

macrophages.

• The macrophages accounts for elevated ACE levels in patients with sarcoidosis.

• ACE is elevated in 60-90% of patients with active sarcoidosis.

• A normal serum ACE does not exclude the diagnosis, especially if the disease is

in its early stages, localized to a small area (e.g. the eye), and therefore with a

small epithelioid cell "burden".

False low values of ACE

• Patients taking ACE inhibitors • Endothelial abnormalities, such as deep vein

thrombosis • Patients who have had chemotherapy or

radiation. • Treatment with systemic steroids or other

immunosupressive agents can also affect ACE levels with values normalizing with adequate control of intraocular inflammation.

Elevated serum ACE

• Gaucher's disease• Leprosy• Chronic pulmonary disease• Rheumatoid arthritis• Spondylitis• Primary biliary cirrhosis• Tuberculosis• Histoplasmosis• Histiocytic medullary fibrosis• Hyperthyroidism• Diabetes mellitus.

Differential diagnosis

• Any cause of chronic granulomatous diseases– Tuberculosis– Syphillis– Herpetic uveitis– Lymphoma– Metastases

Investigations

• In the absence of a known causative agent, sarcoidosis remains a diagnosis of exclusion.

• There are no definitive diagnostic blood, skin, or radiologic imaging tests specific for the disorder.

• Even serum ACE and galluium 67 Scan s are not specific to Sarcoidosis

• Gold standard is demonstration of non caseating granulomas from tissue .

Investigations• CBC, ESR• Mantoux test • Chest X Ray • Serum ACE levels• Lymph Node Biopsy• Broncheo Alveolar Lavage • Trans Bronchial Lung Biopsy

– Other tests• TPHA• Sputum for AFB• Gallium 67 Scan

Gold standard

• In most centers, skin and transbronchial lung biopsies have supplanted biopsy of mediastinal lymph nodes and the liver because of their high yield, greater specificity, and low morbidity.

Radiographic Staging of Pulmonary Sarcoidosis Using Conventional Chest Radiography

Lungs and thoracic lymph nodes are affected in 90% of patients with sarcoidosisClinical staging is based on the pattern of chest radiographic findings:

Stage 0--No abnormality is defined.

Bilateral hilar lymphadenopathy (BHL),stage 1

Stage 1- Hilar and paratracheal adenopathy without parenchymal involvement. Bilateral hilar adenopathy is most common, followed by adenopathy in the right

paratracheal area or aortopulmonary window area on the left.•

BHL with parenchymal infiltrates, stage II

Bilateral hilar adenopathy with Mild interstitial disease in upper lobes.

• Stage 2-Adenopathy with parenchymal involvement. The parenchymal involvement includes a diffuse accentuation of interstitial

markings resulting in a reticular pattern.

Sarcoidosis (with progression from stage II to stage III)

Parenchymal infiltrates, stage III

Signs of fibrosis with shrinkage, stage IV.

CT showing bilateral nodular infiltrates along bronchovascular bundles and enlarged mediastinal lymph nodes

Treatment

• The optimal therapy for sarcoidosis is not well defined; therapeutic decisions are dictated by the localisation of the disease and severity of organ involvement.

• The mainstay of treatment is corticosteroid therapy, which exhibits especially short term beneficial effects.

Treatment

• Steroid sparing drugs for longer term treatment– Methotrexate 10-22.5mg/week – Cyclosporin B 3-5 mg/kgBW/day– Azathioprine 1-3mg/kgBW BID/TID

Local Treatment

• Topical Prednisolone acetate eye drops• Peri-ocular Posterior subtenons triamcinolone

acetonide• Dexamethasone implant in very severe

recurrent cases

Prognosis

• The poor visual prognosis was associated with the advanced age of the patients, black race, female sex, chronic systemic disease, and also with posterior segment involvement, peripheral punched out lesions, and the presence of cystoid macular oedema and glaucoma.

• CME is leading cause of visual loss in sarcoid patients

Thank Youdrrajeshbabu@yahoo.com